News Summary: Generic Lipitor cuts Pfizer’s profit

Published



LIPITOR EFFECT: Drugmaker Pfizer’s third-quarter profit falls 14 percent as sales plunge amid increased generic competition to cholesterol fighter Lipitor, long the world’s top-selling drug. Its sales dove 71 percent to $749 million.

THE RESULTS: Net income was $3.21 billion, or 43 cents per share. Adjusted profit per share was 53 cents per share, a penny less than expected. Revenue fell 16 percent to $13.98 billion, below expectations for $14.66 billion.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.